Skip to content

The effect of Electrical Brain Stimulation in patients with Primary Dysmenorrhea

Transcranial Direct Current Stimulation in women with Primary Dysmenorrhea: usability and clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-747k8vb
Enrollment
Unknown
Registered
2024-04-02
Start date
2024-04-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea

Interventions

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 45 years; medical diagnosis of primary dysmenorrhea according to Guideline Nº 34539; mean pain equal to or greater than 4 on the Visual Analogue Scale of Pain; periodic pain of at least 3 menstrual cycles in a row; having a regular menstrual cycle of 28 to 32 days; no pelvic inflammatory disease; history of head trauma; epilepsy; endometriosis; current pregnancy; chronic abdominal pain unrelated to the menstrual cycle; fibroids; inflammatory bowel syndrome; irritable bowel syndrome; major abdominal or pelvic surgery; alcohol dependence; nicotine or drugs; metallic implant; pacemaker; and chronic urinary tract disease

Exclusion criteria

Exclusion criteria: Severe headache in more than two transcranial stimulation sessions; dizziness or severe migraine in more than two transcranial stimulation sessions; failure to perform 2 or more transcranial stimulation applications

Design outcomes

Primary

MeasureTime frame
This is a main primary outcome that is expected to find a improvement of 30% in pain determined through the visual analogue scale according to pre and post intervention;Improvement of 20% of theta band oscillation measured through electroencephalography according to pre and post intervention

Secondary

MeasureTime frame
Expected to find 30% improvement in pressure pain threshold and tolerance using a pressure algometer according to pre and post intervention;It is expected to find a improvement of 30% of the intensity and interference of pain through the pain inventory according to pre and post intervention;It is expected a 30% of improvement in the submaximal functional capacity assessed through the 6-minute walk test on pre intervention and post intervention;It is expected an improvement of 20% in lower limb strength assessed using the 30-second sit-to-stand test according to pre and post intervention;It is expected an improvement of 20% in power, speed, agility and dynamic balance is expected according to the Timed Up and Go test according to pre and post intervention;It is expected an improvement of 30% is expected in quality of life assessed by the short version of the World Health Organization Quality of Life questionnaire according to pre and post intervention;A moderate improvement of up to 30% is expected in positive and negative affect assessed by the affect scale according to pre and post intervention;A moderate improvement of up to 30% is expected in anxiety measured according to the Hamilton Anxiety Scale according to pre and post intervention;A moderate improvement of up to 30% is expected in depression measured according to the Beck Depression Scale according to pre and post intervention;Improvement of 30% in symptoms related to primary dysmenorrhea as assessed by the Premenstrual Symptom Screening Tool and the Somatic Symptom Scale-8 according to pre and post intervention

Countries

Brazil

Contacts

Public ContactRodrigo Freitas

Universidade Federal do Rio Grande do Norte

rodrigopegado@gmail.com+55(84)33422385

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 3, 2026